ImmuCell Corporation (NASDAQ:ICCC) Q1 2026 Earnings Call Transcript May 15, 2026
Operator: Good morning, and welcome to the ImmuCell Corporation conference call to discuss unaudited first quarter 2026 financial results. [Operator Instructions] Please note this event today is being recorded. I would now like to turn the conference call over to Joe Diaz of Lytham Partners. Please proceed.
Joe Diaz: Thank you, Chris. Good morning, and welcome. As the operator indicated, my name is Joe Diaz with...
